The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1469
ISSUE1469
May 25, 2015
Fluticasone Furoate (Arnuity Ellipta) for Asthma
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Fluticasone Furoate (Arnuity Ellipta) for Asthma
May 25, 2015 (Issue: 1469)
The FDA has approved Arnuity Ellipta (GSK), a single-agent
inhaler containing the corticosteroid fluticasone
furoate, for once-daily maintenance treatment of
asthma in patients ≥12 years old. Fluticasone furoate
is also available in combination...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.